| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 953.81M | 751.27M | 551.19M | 444.18M | 451.15M | 318.21M |
| Gross Profit | 379.98M | 578.05M | 400.06M | 43.54M | 311.85M | 221.55M |
| EBITDA | 79.88M | 56.98M | 43.11M | 32.50M | 32.54M | 27.28M |
| Net Income | 46.55M | 35.37M | 19.26M | 13.41M | 13.56M | 13.35M |
Balance Sheet | ||||||
| Total Assets | 585.86M | 470.97M | 288.15M | 227.42M | 231.98M | 155.56M |
| Cash, Cash Equivalents and Short-Term Investments | 200.55M | 94.32M | 100.97M | 46.74M | 27.88M | 34.18M |
| Total Debt | 105.14M | 51.74M | 29.25M | 27.73M | 27.17M | 19.88M |
| Total Liabilities | 404.49M | 311.19M | 166.98M | 122.44M | 138.56M | 97.85M |
| Stockholders Equity | 181.37M | 159.78M | 121.17M | 104.98M | 93.42M | 57.71M |
Cash Flow | ||||||
| Free Cash Flow | 151.93M | 107.82M | 68.90M | 32.09M | 6.60M | -4.30M |
| Operating Cash Flow | 170.04M | 120.93M | 82.84M | 37.79M | 11.47M | 6.99M |
| Investing Cash Flow | -60.74M | -46.36M | -15.82M | -7.31M | -24.25M | -12.42M |
| Financing Cash Flow | -21.92M | -14.72M | -12.79M | -11.48M | 6.33M | -189.08K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | AU$1.45B | 30.12 | 25.18% | 0.57% | 36.30% | 82.20% | |
69 Neutral | AU$886.75M | 23.20 | 8.35% | 4.17% | -21.57% | -34.09% | |
68 Neutral | AU$792.92M | 28.69 | 50.61% | 5.24% | 12.96% | 8.19% | |
66 Neutral | AU$1.79B | 31.97 | 13.62% | 1.85% | 23.76% | 21.18% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |
GenusPlus Group Ltd. has declared a fully paid dividend of AUD 0.02 per ordinary share for the six-month period ended 31 December 2025, with an ex-dividend date of 31 March 2026 and a record date of 1 April 2026. The payment is scheduled for 24 April 2026, signalling continued cash returns to shareholders in line with its regular half-year distribution timetable and providing income visibility for existing investors.
The announced dividend reinforces GenusPlus Group Ltd.’s commitment to shareholder distributions, indicating that the company is maintaining a capital management policy that supports periodic cash payouts. The clear timetable for ex-date, record date and payment date gives the market certainty around the upcoming distribution and may support investor sentiment toward the stock in the lead-up to the April 2026 payment.
The most recent analyst rating on (AU:GNP) stock is a Buy with a A$8.00 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.
GenusPlus Group reported a strong first half for FY2026, with revenue surging 61% year-on-year to $535.4 million and normalised EBITDA up 69% to $46.3 million, supported by record NPAT of $24.9 million and robust operating cash inflow of $73.7 million. The group’s balance sheet remains solid with $178.1 million in cash, net cash of $127.0 million, a record $2.4 billion order book and a $2.6 billion tender pipeline, underpinning a maiden interim dividend and signalling confidence in sustained growth.
Management highlighted accelerating demand from renewable energy and “rewiring the nation” projects, with recurring revenue forecast to grow 20% in FY2026 and east coast operations contributing an increasing share of sales. Expanded bank guarantee and surety limits, together with strong industry tailwinds as Australia transitions from coal to clean energy, position GenusPlus to capitalise on long-term investment in transmission, distribution, solar and battery storage infrastructure.
The most recent analyst rating on (AU:GNP) stock is a Buy with a A$8.00 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.
GenusPlus Group reported a strong first half for the 2025 financial year, with total revenue from ordinary activities rising 61% to $535.4 million compared with the prior corresponding period. Normalised profit after tax increased 66% to $24.9 million, while net profit attributable to members surged 82% to $24.9 million, reflecting both robust operational performance and lower normalisation adjustments.
The board declared a fully franked interim dividend of 2.0 cents per share, totalling about $3.6 million, following a fully franked final dividend of 3.6 cents per share paid in November 2025. The company’s balance sheet remained solid with net tangible assets per security broadly stable around $0.49, and its growth is underpinned by interests in several large transmission and renewable energy joint ventures, signalling continued exposure to Australia’s expanding energy infrastructure build-out.
The most recent analyst rating on (AU:GNP) stock is a Buy with a A$8.00 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.
GenusPlus Group Ltd has upgraded its earnings guidance for FY2026, forecasting normalised EBITDA growth of about 35% compared with the prior year’s $67.4 million, following stronger-than-expected unaudited results in its Energy & Engineering and Services segments and solid performance in Infrastructure. Management cites recent contract wins, contributions from acquisitions, a strong order book and favourable industry tailwinds linked to the national energy transition as reinforcing confidence in the company’s growth trajectory and resilience, signalling a positive outlook for shareholders and other stakeholders.
The most recent analyst rating on (AU:GNP) stock is a Buy with a A$8.00 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.
GenusPlus Group Ltd has issued 396,721 new unquoted performance rights under its employee incentive scheme, with an expiry date of 1 July 2029. The move underscores the company’s continued use of equity-based incentives to align employees’ interests with long-term shareholder value, potentially strengthening staff retention and engagement without immediate dilution of quoted share capital.
The most recent analyst rating on (AU:GNP) stock is a Buy with a A$7.50 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.
GenusPlus Group Ltd has issued 396,721 performance rights to key management personnel and employees under its Employee Securities Incentive Plan, reinforcing its use of equity-linked incentives to align staff rewards with long-term shareholder outcomes. The rights, granted for no upfront consideration, are subject to performance hurdles based on absolute total shareholder return between July 2025 and June 2028 and continued employment, and may be settled either in shares or cash at the board’s discretion, a structure that could impact future dilution and remuneration outcomes while tying executive incentives closely to the company’s market performance.
The most recent analyst rating on (AU:GNP) stock is a Buy with a A$7.50 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.
GenusPlus Group Ltd has applied to the ASX for quotation of 62,240 new fully paid ordinary shares under its employee incentive scheme. The newly issued securities are not subject to transfer restrictions, indicating the company is continuing to use equity-based remuneration to incentivise staff and align employee interests with shareholder value, although the small number of shares suggests a limited impact on overall capital structure.
The most recent analyst rating on (AU:GNP) stock is a Buy with a A$7.50 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.
GenusPlus Group Ltd has secured a new A$429 million secured revolving syndicated facility with Commonwealth Bank of Australia, HSBC and National Australia Bank, replacing its previous A$147 million club facility. The three-year multi-option facility significantly expands the company’s funding capacity, providing greater financial flexibility to support its ongoing growth strategy amid favourable industry conditions, and, together with existing surety bond facilities, creates substantial headroom for future expansion and capital needs.
The most recent analyst rating on (AU:GNP) stock is a Buy with a A$7.50 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.
GenusPlus Group Ltd has confirmed the commencement of construction for the Hunter-Central Coast Renewable Energy Zone sub-transmission line works, following the execution of a Project Deed with Ausgrid and the Energy Corporation of New South Wales. The contract, valued at approximately $140 million, involves significant infrastructure upgrades, including the demolition and construction of sub-transmission lines and the installation of advanced communication cables, with completion expected by Q1 2028. This project positions GenusPlus as a key player in supporting renewable energy infrastructure in Australia.
The most recent analyst rating on (AU:GNP) stock is a Buy with a A$7.50 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.
GenusPlus Group Ltd, in partnership with ACCIONA, has been awarded a significant contract by AusNet to construct the Western Renewables Link in Victoria, valued at approximately AUD$1.6 billion. This project, which aims to enhance Victoria’s renewable energy infrastructure, will involve the construction of a 500 kV transmission line and is expected to generate substantial economic and community benefits, including job creation and long-term advantages for the local economy.
The most recent analyst rating on (AU:GNP) stock is a Buy with a A$6.00 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.
GenusPlus Group Ltd. has announced a change in the director’s interest notice involving David William Riches. The change involves the acquisition of 357,277 fully paid ordinary shares valued at $1,800,000 as contingent consideration for the acquisition of shares in Partum Engineering Pty Ltd. This transaction reflects a strategic move by GenusPlus to consolidate its interests, potentially impacting its operational dynamics and stakeholder relationships.
The most recent analyst rating on (AU:GNP) stock is a Buy with a A$6.00 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.
GenusPlus Group Ltd announced the release of 2,460,937 fully paid ordinary shares from voluntary escrow, linked to its acquisition of Partum Engineering Pty Ltd. This release signifies a strategic move following the acquisition, with 357,277 shares remaining under escrow until December 2026, potentially impacting shareholder value and market perception.
The most recent analyst rating on (AU:GNP) stock is a Buy with a A$6.00 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.
GenusPlus Group Ltd has announced the quotation of 357,277 fully paid ordinary securities on the Australian Securities Exchange (ASX) as of December 1, 2025. This move is part of a previously announced transaction, potentially enhancing the company’s market presence and providing additional liquidity for stakeholders.
The most recent analyst rating on (AU:GNP) stock is a Buy with a A$6.00 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.
GenusPlus Group Ltd has announced the appointment of Tony Narvaez as a director, effective from November 21, 2025. The Initial Director’s Interest Notice reveals that Tony Narvaez currently holds no relevant interests in securities, either as a registered holder or otherwise, and has no interests in contracts related to the company. This announcement is part of the company’s compliance with ASX listing rules, ensuring transparency in its governance practices.
The most recent analyst rating on (AU:GNP) stock is a Buy with a A$6.00 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.